What is the main business of Farmagen?

The main business activity of Farmagen focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on June 21, 2004.

Where is the headquarters located?

The headquarters is located at: Międzynarodowa 50 A, 03-922 Warszawa.

What is the share capital?

The share capital of the company is PLN 50,000 (approx. $13,506).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

In 2024, the company generated total revenue of $5,159, representing a decrease of 76.8% compared to 2023.

Is the company profitable?

No, the company recorded a net loss of $2,319 in 2024.

Which cost dominates operating expenses?

The largest operating cost category falls under employee remuneration. This category amounted to $1,442 in 2024, representing 20% of all operating expenses.

Farmagensp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2004-06-21

Share capital

50,000.00 PLN

Registered address

Międzynarodowa 50 A/23, 03-922 Warszawa, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 4 of 6 financial statements were filed late (the longest delay 212 days for 2024), 1 not filed.

2025not filed
202412/02/2026
202327/11/2024
202220/04/2023
2021not filed
202013/05/2022

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue

This companyUSD 5.16kMedianUSD 1.06mAverageUSD 22.41m

Net profit

This companyUSD -2.32kMedianUSD 37.20kAverageUSD 879.46k

Operating costs

This companyUSD 7.39kMedianUSD 921.66kAverageUSD 21.08m

Assets

This companyUSD 213.86kMedianUSD 609.79kAverageUSD 11.85m

Industry

Authorized Representatives

Danuta Szczechowicz – President of the Management Board

Patrycja Szczechowicz – Management Board Member

Patryk Szczechowicz – Attorney-in-fact (sole)

Manner of representation

The President of the Management Board independently, or two members of the management board jointly, or a member of the management board jointly with a commercial proxy.

Ownership

Owner	Shares	Share value	Stake
Patrycja Szczechowiczage 42	10	$1,350.62	10%
Patryk Szczechowiczage 49	90	$12,155.59	90%

Patryk Szczechowicz and Patrycja Szczechowicz hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2004-01-21.

mBank
93 1140 2004 0000 3812 0343 0931
mBank
71 1140 2004 0000 3102 7550 1831

Debt

No entries in the National Debtors Register (KRZ).

Public aid

Grant date	Purpose	Gross amount	Granting body
Jul 2, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$1,282$1,282	Prezydent Miasta Stołecznego Warszawy

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Competitors

Name	Revenue	Website
Ivoclar-Vivadent Polskasp. z o.o.	$17,154,419.26	ivoclar.com
Billmedsp. z o.o.	$5,738,714.60	e.pl
Medmess Kropaczewskisp. k.	$4,516,614.15	medmess.pl
THC PharmaS.A.	$39,093.70	thc-pharma.pl
EDGE Pharmasp. z o.o.	$19,855.64	edgepharma.eu
Arcade Internationalsp. z o.o.	$17,817.26	arcade-int.pl
Filicosp. z o.o.	$11,710.75	filico.eu
Get Ready Wheelchairssp. z o.o.	$9,842.54	getreadywheelchairs.com
Jacek Waksmundzki Trust 2S.K.A.	$5,769.53	trust.pl
Optimedussp. z o.o.	$1.00	optimedus.pl

Change history

Date	Event
2015-01-20	Name change ("tratoria Inc." → Farmagen)
2015-01-20	Switch to PKD 2007 (38 PKD 2004 codes → 10 PKD 2007 codes)
2004-06-21	Entered in the register

FAQ

Last updated: 2026-04-10